FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382199942> ?p ?o ?g. }

• W4382199942 endingPage "104858" @default.
• W4382199942 startingPage "104858" @default.
• W4382199942 abstract "Background Wellness is a promising area of research in multiple sclerosis (MS); however, considerable questions remain regarding the efficacy of behavioral interventions to improve wellness and which delivery methods yield favorable results. Objective To evaluate the efficacy of a wellness intervention consisting of diet, stress reduction techniques, sleep hygiene, and exercise, delivered via a 7-week web-based program with no tailored intervention support (e.g., counseling or resources) from the study team, on quality of life (QoL) and fatigue among people with MS. Methods Individuals (n = 100) with self-reported physician's diagnosis of relapsing-remitting MS or clinically isolated syndrome were recruited to enroll in this randomized waitlist-control trial consisting of three timepoints at 0, 12, and 24 weeks. Participants were randomized to begin the intervention at baseline (INT; n = 51) or to a waitlist to begin the intervention after the 12-week timepoint (WLC; n = 49), and both groups were followed for 24 weeks. Results At 12-weeks, 95 participants (46 INT and 49 WLC) completed the primary endpoint and 86 (42 INT and 44 WLC) completed the 24-week follow-up. Compared to baseline, the INT group had a significant increase in physical QoL (5.43 ± 1.85; P = 0.003) at 12-weeks which was maintained at 24-weeks. Physical QoL values in the WLC group did not significantly increase between weeks 12 and 24 (3.24 ± 2.03; P = 0.11); however, physical QoL values significantly improved compared to week 0 values (4.00 ± 1.87; P = 0.033). Neither group had significant changes in mental QoL. The INT group had a mean baseline to 12-week change of ‑5.06 ± 1.79 (P = 0.005) for MFIS and -0.68 ± 0.21 (P = 0.002) for FSS, both of which were maintained at 24-weeks. The 12- to 24-week changes for the WLC group were -4.50 ± 1.81 (P = 0.013) for MFIS and -0.44 ± 0.17 (P = 0.011) for FSS. At 12-weeks, the INT group had significantly greater reductions in fatigue compared to the WLC (P = 0.009 for both MFIS and FSS). There were no between-group mean differences for physical or mental QoL, but a significantly higher proportion of participants had clinically significant improvement in physical QoL in the INT group (50%) compared to the WLC group (22.5%) at 12-weeks (P = 0.006). The 12-week intervention effect was similar during the active intervention phase (i.e., baseline to 12 weeks for INT and 12 to 24 weeks for WLC) in each group. Course completion rates significantly differed between groups with 47.9% of the INT group and 18.8% of the WLC group completing the course (P = 0.01). Conclusion A wellness intervention delivered via a web-based program, without tailored support, resulted in significant improvements in fatigue compared to control. Trial Registration Clinicaltrials.gov Identifier: NCT05057676" @default.
• W4382199942 created "2023-06-28" @default.
• W4382199942 creator A5023922874 @default.
• W4382199942 creator A5025309995 @default.
• W4382199942 creator A5025912572 @default.
• W4382199942 creator A5034946918 @default.
• W4382199942 creator A5068908077 @default.
• W4382199942 creator A5069753020 @default.
• W4382199942 creator A5072842674 @default.
• W4382199942 creator A5079407407 @default.
• W4382199942 date "2023-09-01" @default.
• W4382199942 modified "2023-10-16" @default.
• W4382199942 title "Evaluation of a web-based program for the adoption of wellness behaviors to self-manage fatigue and improve quality of life among people with multiple sclerosis: A randomized waitlist-control trial" @default.
• W4382199942 cites W2024722741 @default.
• W4382199942 cites W2047668388 @default.
• W4382199942 cites W2074891612 @default.
• W4382199942 cites W2096592842 @default.
• W4382199942 cites W2128000797 @default.
• W4382199942 cites W2138405681 @default.
• W4382199942 cites W2142635246 @default.
• W4382199942 cites W2143040468 @default.
• W4382199942 cites W2152160548 @default.
• W4382199942 cites W2156610258 @default.
• W4382199942 cites W2606633191 @default.
• W4382199942 cites W2612749784 @default.
• W4382199942 cites W2626858991 @default.
• W4382199942 cites W2789566453 @default.
• W4382199942 cites W2894796500 @default.
• W4382199942 cites W2900678139 @default.
• W4382199942 cites W2907421343 @default.
• W4382199942 cites W2945419470 @default.
• W4382199942 cites W2947810462 @default.
• W4382199942 cites W2949008890 @default.
• W4382199942 cites W2964415972 @default.
• W4382199942 cites W2982480300 @default.
• W4382199942 cites W3017229861 @default.
• W4382199942 cites W3086335784 @default.
• W4382199942 cites W3113532728 @default.
• W4382199942 cites W3205594150 @default.
• W4382199942 cites W3214761183 @default.
• W4382199942 cites W4210783654 @default.
• W4382199942 cites W4221016496 @default.
• W4382199942 cites W4225384346 @default.
• W4382199942 cites W4235092737 @default.
• W4382199942 cites W4285740817 @default.
• W4382199942 cites W4296139420 @default.
• W4382199942 cites W4300687566 @default.
• W4382199942 cites W4306721670 @default.
• W4382199942 cites W4306721711 @default.
• W4382199942 doi "https://doi.org/10.1016/j.msard.2023.104858" @default.
• W4382199942 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37399671" @default.
• W4382199942 hasPublicationYear "2023" @default.
• W4382199942 type Work @default.
• W4382199942 citedByCount "0" @default.
• W4382199942 crossrefType "journal-article" @default.
• W4382199942 hasAuthorship W4382199942A5023922874 @default.
• W4382199942 hasAuthorship W4382199942A5025309995 @default.
• W4382199942 hasAuthorship W4382199942A5025912572 @default.
• W4382199942 hasAuthorship W4382199942A5034946918 @default.
• W4382199942 hasAuthorship W4382199942A5068908077 @default.
• W4382199942 hasAuthorship W4382199942A5069753020 @default.
• W4382199942 hasAuthorship W4382199942A5072842674 @default.
• W4382199942 hasAuthorship W4382199942A5079407407 @default.
• W4382199942 hasConcept C118552586 @default.
• W4382199942 hasConcept C126322002 @default.
• W4382199942 hasConcept C159110408 @default.
• W4382199942 hasConcept C168563851 @default.
• W4382199942 hasConcept C1862650 @default.
• W4382199942 hasConcept C203092338 @default.
• W4382199942 hasConcept C27415008 @default.
• W4382199942 hasConcept C2779951463 @default.
• W4382199942 hasConcept C2780640218 @default.
• W4382199942 hasConcept C2780665704 @default.
• W4382199942 hasConcept C71924100 @default.
• W4382199942 hasConceptScore W4382199942C118552586 @default.
• W4382199942 hasConceptScore W4382199942C126322002 @default.
• W4382199942 hasConceptScore W4382199942C159110408 @default.
• W4382199942 hasConceptScore W4382199942C168563851 @default.
• W4382199942 hasConceptScore W4382199942C1862650 @default.
• W4382199942 hasConceptScore W4382199942C203092338 @default.
• W4382199942 hasConceptScore W4382199942C27415008 @default.
• W4382199942 hasConceptScore W4382199942C2779951463 @default.
• W4382199942 hasConceptScore W4382199942C2780640218 @default.
• W4382199942 hasConceptScore W4382199942C2780665704 @default.
• W4382199942 hasConceptScore W4382199942C71924100 @default.
• W4382199942 hasLocation W43821999421 @default.
• W4382199942 hasLocation W43821999422 @default.
• W4382199942 hasOpenAccess W4382199942 @default.
• W4382199942 hasPrimaryLocation W43821999421 @default.
• W4382199942 hasRelatedWork W2055573962 @default.
• W4382199942 hasRelatedWork W2139437222 @default.
• W4382199942 hasRelatedWork W2355769538 @default.
• W4382199942 hasRelatedWork W2770864300 @default.
• W4382199942 hasRelatedWork W2898081386 @default.
• W4382199942 hasRelatedWork W2913897113 @default.
• W4382199942 hasRelatedWork W2953033600 @default.
• W4382199942 hasRelatedWork W3016997033 @default.
• W4382199942 hasRelatedWork W4385842477 @default.

• next